1216526

Eugene Chang — FEI 3027540511

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 1, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Pasadena, CA (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
756021 CFR 312.60FD-1572, protocol compliance